Loading institutional data...
Loading institutional data...
Held by 228 of 5,944 reporting institutions (92th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441.3M 100.0% | $388.5M 100.0% | $354.0M 100.0% | $313.8M 100.0% | $298.8M 100.0% | $253.2M 100.0% | $276.2M 100.0% | $262.8M 100.0% | $189.7M 100.0% | $180.4M 100.0% |
| Cost of Revenue | $157.1M 35.6% | $139.8M 36.0% | $124.8M 35.3% | $111.3M 35.5% | $101.3M 33.9% | $85.4M 33.7% | $93.2M 33.7% | $89.9M 34.2% | $61.1M 32.2% | $61.5M 34.1% |
| Cost of Products | — | — | — | — | — | — | — | — | $29.8M 15.7% | $28.0M 15.5% |
| Cost of Services | — | — | — | — | — | — | — | — | $31.3M 16.5% | $33.4M 18.5% |
| Gross Profit | $284.2M 64.4% | $248.8M 64.0% | $229.2M 64.7% | $202.5M 64.5% | $197.5M 66.1% | $167.8M 66.3% | $183.0M 66.3% | $173.0M 65.8% | $128.6M 67.8% | $118.9M 65.9% |
| Research & Development | $31.0M 7.0% | $28.5M 7.3% | $28.7M 8.1% | $38.9M 12.4% | $35.5M 11.9% | $24.2M 9.6% | $23.0M 8.3% | $23.1M 8.8% | $19.5M 10.3% | $13.4M 7.5% |
| Selling, General & Admin | $226.5M 51.3% | $181.5M 46.7% | $209.0M 59.0% | $157.4M 50.2% | $169.8M 56.8% | $141.1M 55.7% | $143.0M 51.8% | $140.6M 53.5% | $101.2M 53.4% | $91.5M 50.8% |
| Total Operating Expenses | $257.5M 58.3% | $209.9M 54.0% | $237.7M 67.1% | $196.3M 62.6% | $205.3M 68.7% | $165.3M 65.3% | $166.0M 60.1% | $163.7M 62.3% | $120.7M 63.6% | $105.0M 58.2% |
| Operating Income | $33.7M 7.6% | $38.9M 10.0% | $5.7M 1.6% | $6.2M 2.0% | $8.1M 2.7% | $2.4M 1.0% | $17.0M 6.2% | $9.3M 3.5% | $8.0M 4.2% | $21.8M 12.1% |
| Interest Expense | $26.6M 6.0% | $34.3M 8.8% | $25.3M 7.1% | $18.2M 5.8% | $16.9M 5.7% | $16.7M 6.6% | $14.9M 5.4% | $15.8M 6.0% | $4.9M 2.6% | $3.0M 1.7% |
| Interest & Investment Income | $763K 0.2% | $1.5M 0.4% | $1.1M 0.3% | $147K 0.0% | $79K 0.0% | $217K 0.1% | $738K 0.3% | $226K 0.1% | $212K 0.1% | $72K 0.0% |
| Other Income (Expense), net | $9.5M 2.2% | -$9.9M -2.6% | -$3.1M -0.9% | -$3.1M -1.0% | -$6.1M -2.1% | -$3.1M -1.2% | -$1.3M -0.5% | -$141K -0.1% | $260K 0.1% | -$437K -0.2% |
| Pretax Income | $14.8M 3.3% | -$7.5M -1.9% | -$21.6M -6.1% | -$15.0M -4.8% | -$14.8M -5.0% | -$17.2M -6.8% | $1.6M 0.6% | -$6.4M -2.4% | $3.6M 1.9% | $18.4M 10.2% |
| Income Tax Expense | $5.0M 1.1% | $5.8M 1.5% | $9.1M 2.6% | $4.2M 1.3% | $7K 0.0% | -$492K -0.2% | -$76K -0.0% | -$3.6M -1.4% | -$143K -0.1% | $7.6M 4.2% |
| Net Income | $9.8M 2.2% | -$13.4M -3.4% | -$30.7M -8.7% | -$19.2M -6.1% | -$14.8M -5.0% | -$16.7M -6.6% | $1.7M 0.6% | -$2.8M -1.1% | $3.7M 2.0% | $10.8M 6.0% |
| Per Share | ||||||||||
| EPS (Basic) | $0.22 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.33 |
| EPS (Diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 |
| Weighted Avg Shares (Basic) | 45.3M | 41.7M | 40.7M | 40.0M | 39.0M | 37.9M | 37.1M | 36.4M | 33.0M | 31.9M |
| Weighted Avg Shares (Diluted) | 47.2M | 41.7M | 40.7M | 40.0M | 39.0M | 37.9M | 37.9M | 36.4M | 34.2M | 32.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $23.88 today, the market must believe free cash flow compounds 38.2%/yr for a decade (off $7M normalized FCF).
The market's 38.2% is more optimistic than its 9-yr track record.
2-stage DCF · 0.05B shares · net debt $150M
mean -71.2% · volatility σ 161% · implied rate exceeded in 1/7 yrs
Central path = implied 38.2%/yr growth; shaded band = ±1σ (161%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $839000 FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 1%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $65M covers the $0 due within a year 64908000.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~12.4% on $215M of debt.
Cash of $65M fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
Where each multiple sits in its own 14-yr range · 44th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 34.2 | 33.7 | 33.7 | 33.9 | 35.5 | 35.3 | 36.0 | 35.6 |
| Gross Profit | 65.8 | 66.3 | 66.3 | 66.1 | 64.5 | 64.7 | 64.0 | 64.4 |
| R&D | 8.8 | 8.3 | 9.6 | 11.9 | 12.4 | 8.1 | 7.3 | 7.0 |
| SG&A | 53.5 | 51.8 | 55.7 | 56.8 | 50.2 | 59.0 | 46.7 | 51.3 |
| Operating Income | 3.5 | 6.2 | 1.0 | 2.7 | 2.0 | 1.6 | 10.0 | 7.6 |
| Income Tax | -1.4 | -0.0 | -0.2 | 0.0 | 1.3 | 2.6 | 1.5 | 1.1 |
| Net Income | -1.1 | 0.6 | -6.6 | -5.0 | -6.1 | -8.7 | -3.4 | 2.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on AORT: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| AORT | $1.1B | 113.7× | 21.9× | 2.5× | 13.6% | 64.4% | 2.2% | 2.2% | 1.5% | 3.8× | 228 |
Peers = companies sharing AORT's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.